Mira Chaurushiya

GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.

Westlake Biopartners LLC (Westlake Biopartners) is a venture capital firm founded in 2018. The firm is headquartered in Westlake Village, California.

The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish.

Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA.

Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada.

EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA.

5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.